ESC 365 - SGLT2 inhibitors: beyond their glucose-lowering effects.

Open Access

SGLT2 inhibitors: beyond their glucose-lowering effects.

Session: Dyslipidaemia and type 2 diabetes - the two ugly sisters

Topic: Lipids

Speaker: Professor A. Avogaro (Padova, IT)

Event: ESC Preventive Cardiology 2021

Congress Presentation

Add to my library

About the speaker

Professor Angelo Avogaro

Padova Hospital, Padova (Italy)

5 presentations

1 follower

4 more presentations in this session

Dyslipidaemia in type 2 diabetes: scope of the problem.

Speaker: Professor F. Mach (Geneva, CH)

When statins are not enough: emerging pharmacological tools.

Speaker: Professor U. Landmesser (Berlin, DE)

Triglyceride-rich lipoproteins: is weight loss the solution?

Speaker: Professor J. Armitage (Oxford, GB)

Dyslipidaemia and type 2 diabetes - the two ugly sisters - discussion.

Access the full session

Dyslipidaemia and type 2 diabetes - the two ugly sisters

Speakers: Professor A. Avogaro, Professor F. Mach, Professor U. Landmesser, Professor J. Armitage

About the event

ESC Preventive Cardiology 2021

15 April - 17 April 2021

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources